AQP4 and myeloid sarcoma: Unlike MS (in which no particular antibody has been firmly linked to pathophysiology), a convergence of pathologic (121–125) and clinical (126–131) observations supports a pathophysiologic role of anti-AQP-4 antibodies in NMOSD [reviewed by Ref.